Fasting whole blood fatty acid profile and risk of type 2 diabetes in adults: A nested case control study

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Alhazmi, Amani ^a,b   Stojanovski, Elizabeth ^c   Garg, Manohar L ^a   McEvoy, Mark ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b Ministry of Education Saudi Arabia   (Saudi Arabia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; LIGNOCERIC ACID; LINOLENIC ACID; ACYL COENZYME A DESATURASE;

ADULT; AGED; ARTICLE; AUSTRALIA; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FATTY ACID BLOOD LEVEL; FEMALE; GAS CHROMATOGRAPHY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; VERY ELDERLY; BLOOD; DIABETES MELLITUS, TYPE 2; DIET RESTRICTION; ENZYMOLOGY; METABOLISM; RISK;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FATTY ACID DESATURASES; FATTY ACIDS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK;

EID: 84901194589     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097001     Document Type: Article

References (43)

1. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053. (Pubitemid 38579764)
2. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87: 4-14.
3. Djousse L, Biggs ML, Lemaitre RN, King IB, Song X, et al. (2011) Plasma omega-3 fatty acids and incident diabetes in older adults. Am J Clin Nutr 94: 527-533.
4. Djoussé L, Gaziano JM, Buring JE, Lee I-M (2011) Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes. Am J Clin Nutr 93: 143-150.
5. Villegas R, Xiang Y-B, Elasy T, Li H-L, Yang G, et al. (2011) Fish, shellfish, and long-chain n-3 fatty acid consumption and risk of incident type 2 diabetes in middle-aged Chinese men and women. Am J Clin Nutr 94: 543-551.
6. Wallin A, Di Giuseppe D, Orsini N, Patel PSM, Forouhi NGF, et al. (2012) Fish Consumption, Dietary Long-Chain n-3 Fatty Acids, and Risk of Type 2 Diabetes: Systematic review and meta-analysis of prospective studies. Diabetes Care 35: 918-929.
7. Meyer KA, Kushi LH, Jacobs DR Jr, Folsom AR (2001) Dietary fat and incidence of type 2 diabetes in older Iowa women. Diabetes Care 24: 1528-1535. (Pubitemid 33716444)
8. van Dam RM, Willett WC, Rimm EB, Stampfer MJ, Hu FB, et al. (2002) Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 25: 417-424. (Pubitemid 41103330)
9. Hu FB, van Dam RM, Liu S (2001) Diet and risk of type II diabetes: the role of types of fat and carbohydrate. Diabetologia 44: 805-817. (Pubitemid 32642452)
10. Salmeron J, Hu FB, Manson JE, Stampfer MJ, Colditz GA, et al. (2001) Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 73: 1019-1026. (Pubitemid 32496939)
11. Laaksonen DE, Lakka TA, Lakka HM, Nyyssonen K, Rissanen T, et al. (2002) Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabet Med 19: 456-464. (Pubitemid 34639155)
12. Wang L, Folsom AR, Zheng Z-J, Pankow JS, Eckfeldt JH, et al. (2003) Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 78: 91-98. (Pubitemid 39655252)
13. Hodge AM, English DR, O'Dea K, Sinclair AJ, Makrides M, et al. (2007) Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. Am J Clin Nutr 86: 189-197. (Pubitemid 47041610)
14. Vessby B, Aro A, Skarfors E, Berglund L, Salminen I, et al. (1994) The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes 43: 1353-1357.
15. Baylin A, Kim MK, Donovan-Palmer A, Siles X, Dougherty L, et al. (2005) Fasting Whole Blood as a Biomarker of Essential Fatty Acid Intake in Epidemiologic Studies: Comparison with Adipose Tissue and Plasma. Am J Epidemiol 162: 373-381. (Pubitemid 41389719)
16. McEvoy M, Smith W, D'Este C, Duke J, Peel R, et al. (2010) Cohort profile: The Hunter Community Study. Int J Epidemiol 39: 1452-1463.
17. Lepage G, Roy CC (1986) Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27: 114-120. (Pubitemid 16045295)
18. Smith W, Mitchell P, Reay EM, Webb K, Harvey PW (1998) Validity and reproducibility of a self-administered food frequency questionnaire in older people. Aust N Z J Public Health 22: 456-463. (Pubitemid 28339687)
19. Food Standards Australia New Zealand (2006) NUTTAB Australian Food Composition Tables(2006).Department of Health and Ageing Canberra, ACT, Australia.
20. Willett W, Stampfer MJ (1986) Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124: 17-27. (Pubitemid 16095831)
21. Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc Series B Stat Methodol 57: 289-300.
22. Williams MD, Nadler JL (2007) Inflammatory mechanisms of diabetic complications. Curr Diab Rep 7: 242-248. (Pubitemid 46951922)
23. Fan YY, Chapkin RS (1992) Mouse peritoneal macrophage prostaglandin E1 synthesis is altered by dietary gamma-linolenic acid. J Nutr 122: 1600-1606.
24. Funk CD (2001) Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology. Science 294: 1871-1875.
25. Nakamura MT, Nara TY (2004) Structure, function, and dietary regulation of Δ6, Δ5, and Δ9 desaturases Ann Rev Nutr 24: 345-376.
26. Das UN (2013) Arachidonic acid and lipoxin A4 as possible endogenous antidiabetic molecules. Prostaglandins Leukot Essent Fatty Acids 88: 201-210.
27. Alhazmi A, Stojanovski E, McEvoy M, Garg ML (2013) Macronutrient intake and type 2 diabetes risk in middle-aged Australian women. Results from the Australian Longitudinal Study on Women's Health. Public Health Nutr doi:10.1017/S1368980013001870
28. Dayton S, Hashimoto S, Dixon W, Pearce ML (1966) Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. J Lipid Res 7: 103-111.
29. Sacks FM, Stampfer MJ, Munoz A, McManus K, Canessa M, et al. (1987) Effect of linoleic and oleic acids on blood pressure, blood viscosity, and erythrocyte cation transport. J Am Coll Nutr 6: 179-185.
30. Vidgren HM, Agren JJ, Schwab U, Rissanen T, Hanninen O, et al. (1997) Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. Lipids 32: 697-705. (Pubitemid 27328050)
31. Kaushik M, Mozaffarian D, Spiegelman D, Manson JE, Willett WC, et al. (2009) Long-chain omega-3 fatty acids, fish intake, and the risk of type 2 diabetes mellitus. Am J Clin Nutr 90 (3): 613-620.
32. Alhazmi A, Stojanovski E, McEvoy M, Garg ML (2012) Macronutrient intakes and development of type 2 diabetes: a systematic review and meta-analysis of cohort studies. J Am Coll Nutr 31: 243-258.
33. Mata P, Alonso R, Lopez-Farre A, Ordovas JM, Lahoz C, et al. (1996) Effect of dietary fat saturation on LDL oxidation and monocyte adhesion to human endothelial cells in vitro. Arterioscler Thromb Vasc Biol 16: 1347-1355. (Pubitemid 26378225)
34. Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF, et al. (2002) Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr 76: 1007-1015. (Pubitemid 35244671)
35. Puhakainen I, Ahola I, Yki-Jarvinen H (1995) Dietary supplementation with n-3 fatty acids increases gluconeogenesis from glycerol but not hepatic glucose production in patients with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 61: 121-126.
36. Carpentier YA, Portois L, Malaisse WJ (2006) n-3 fatty acids and the metabolic syndrome. Am J Clin Nutr 83: 1499S-1504S. (Pubitemid 44713091)
37. Mostad IL, Bjerve KS, Bjorgaas MR, Lydersen S, Grill V (2006) Effects of n-3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation. Am J Clin Nutr 84: 540-550. (Pubitemid 44713403)
38. Montanaro MA, Rimoldi OJ, Igal RA, Montenegro S, Tarres MC, et al. (2003) Hepatic delta9, delta6, and delta5 desaturations in non-insulin-dependent diabetes mellitus eSS rats. Lipids 38: 827-832. (Pubitemid 37193743)
39. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, et al. (2002) Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346: 1113-1118. (Pubitemid 34984601)
40. Godley PA, Campbell MK, Miller C, Gallagher P, Martinson FE, et al. (1996) Correlation between biomarkers of omega-3 fatty acid consumption and questionnaire data in African American and Caucasian United States males with and without prostatic carcinoma. Cancer Epidemiol Biomarkers Prev 5: 115-119.
41. El Fakiri F, Bruijnzeels MA, Hoes AW (2007) No evidence for marked ethnic differences in accuracy of self-reported diabetes, hypertension, and hypercholesterolemia. J Clin Epidemiol 60: 1271-1279. (Pubitemid 350061140)
42. Hu FB, Leitzmann MF, Stampfer MJ, Colditz GA, Willett WC, et al. (2001) Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med 161: 1542-1548. (Pubitemid 32679568)
43. Lowe J, Byles J, Dolja-Gore X, Young A (2010) Does systematically organized care improve outcomes for women with diabetes? J Eval Clin Pract 16: 887-894.